1.

Immune responses after two- versus three-doses of HPV vaccination up to 4½ years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D)

2.

Immune responses after two- versus three-doses of HPV vaccination up to 4½ years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D)

1.

IL‐1B promoter polymorphism and Epstein‐Barr virus in Dutch patients with gastric carcinoma

2.

IL‐1B promoter polymorphism and Epstein‐Barr virus in Dutch patients with gastric carcinoma

1.

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based ra...

2.

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based ra...

3.

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based ra...

4.

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based ra...

5.

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based ra...

1.

Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands

2.

Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands

1.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao

2.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao

3.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao

4.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao

5.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao

1.

Population- and Type-Specific Clustering of Multiple HPV Types Across Diverse Risk Populations in the Netherlands

2.

Population- and Type-Specific Clustering of Multiple HPV Types Across Diverse Risk Populations in the Netherlands

3.

Population- and Type-Specific Clustering of Multiple HPV Types Across Diverse Risk Populations in the Netherlands

4.

Population- and Type-Specific Clustering of Multiple HPV Types Across Diverse Risk Populations in the Netherlands

5.

Population- and Type-Specific Clustering of Multiple HPV Types Across Diverse Risk Populations in the Netherlands

1.

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

2.

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

1.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

2.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

3.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

4.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

5.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

6.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

7.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

8.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

9.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:Results from a Dutch primary HPV-based screening cohort

1.

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV‐positive women: Results from a Dutch primary HPV‐based screening cohort...